The trial in the ACCC’s case against hospital group Ramsay Health Care has doubled in length after the regulator made a late bid to enter as evidence a file note based on a sound recording of a meeting in which a Ramsay unit’s CEO allegedly made anti-competitive threats.
ANZ has reached a settlement in long-running class action proceedings alleging it hit customers with illegal fees, but the $1.5 million payout falls far short of the many millions IMF Bentham spent in funding the matter.
The High Court has upheld a $1.3 million damages award to native title holders in the Northern Territory town of Timber Creek for their loss of spiritual attachment to the land, in the first ever assessment by the court of native title compensation.
Customer credit card information and other personal details may have been stolen during a breach of Kathmandu’s online system, the outdoor clothing retailer has revealed.
The courts should be given express statutory power to resolve competing class actions that establishes the factors to consider when picking a winning case, a leading class action judge has said.
Competing class actions that drag out proceedings can have devastating effects on group members, and whether funded class actions provide genuine access to justice, not just “access to the court’s processes”, was a legitimate question, the head of the Australian Law Reform Commission said Wednesday.
A Mildura-based healthcare company and its boss have been committed to stand trial in the first criminal cartel case brought by the Australian Competition and Consumer Commission against an Australian business.
Piper Alderman and a senior female partner who has accused the law firm’s leaders of sex discrimination have been unable to settle their dispute out of the glare of the courtroom.
Leading solar panel manufacturer Hanwha Q CELLS has launched a patent lawsuit against two of its biggest competitors for allegedly importing solar products into Australia that infringe its patented solar technology.
An eight-day joint hearing in cases brought by Allergan alleging infringement of its Botox trade mark, which was due to commence Monday, has been unexpectedly vacated by the court, with barristers and legal teams left in the dark about the reasons.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
